BackJacobio Pharmaceuticals Group , Ltd. Overview

Jacobio Pharmaceuticals Group , Ltd. Intangible Assets

Latest intangible assets for 1167.HK: $1.1M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$1.07M
↓ 12.59% YoYΔ $-154197.00 vs prior year quarter

Peer trimmed avg / median

Loading

Jacobio Pharmaceuticals Group , Ltd. Intangible Assets History

Loading

Jacobio Pharmaceuticals Group , Ltd. vs. peers: Intangible Assets Comparison

Loading

Jacobio Pharmaceuticals Group , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Jacobio Pharmaceuticals Group , Ltd. (1167.HK) FAQ

As of the most recent data (June 2026), 1167.HK shows a intangible assets of $1.1M. That compares with $1.2M in the prior-year period — down 12.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1167.HK's intangible assets is now $1.1M (was $1.2M) — a 12.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jacobio Pharmaceuticals Group , Ltd. is outperforming or lagging.

Tracking 1167.HK's intangible assets over time shows whether Jacobio Pharmaceuticals Group , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $1.2M in the prior-year period — down 12.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Jacobio Pharmaceuticals Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $1.1M) with ownership activity and broader fundamentals.

Jacobio Pharmaceuticals Group , Ltd.'s intangible assets is $1.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.